Your browser doesn't support javascript.
loading
CRISPR/deadCas9-based high-throughput gene doping analysis (HiGDA): A proof of concept for exogenous human erythropoietin gene doping detection.
Yi, Joon-Yeop; Kim, Minyoung; Ahn, Jung Ho; Kim, Byung-Gee; Son, Junghyun; Sung, Changmin.
Affiliation
  • Yi JY; Doping Control Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea; Interdisciplinary Program of Bioengineering, Seoul National University, Seoul, 08826, South Korea; Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, South Korea.
  • Kim M; Doping Control Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea.
  • Ahn JH; Clean Energy Research Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea.
  • Kim BG; Interdisciplinary Program of Bioengineering, Seoul National University, Seoul, 08826, South Korea; Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, South Korea; Bio-Max/N-Bio Institute, Seoul National University, Seoul, 08826, South Korea; School of Chemical and
  • Son J; Doping Control Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea.
  • Sung C; Doping Control Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea. Electronic address: scm@kist.re.kr.
Talanta ; 258: 124455, 2023 Jun 01.
Article in En | MEDLINE | ID: mdl-36933297

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / CRISPR-Cas Systems Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Talanta Year: 2023 Document type: Article Affiliation country: South Korea

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / CRISPR-Cas Systems Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Talanta Year: 2023 Document type: Article Affiliation country: South Korea